On January 23, 2017, Ms. Jean Arnett resigned as the Vice President, Corporate Development and as a director of Cell MedX Corp. Ms. Arnett's resignation was not due to, and was not caused by, in whole or in part, any disagreement with the Company, whether related to the Company's operations, policies, practices or otherwise. To fill the vacancy on the Board of Directors the Company appointed Bradley Hargreaves as a director of the Company. Mr. Hargreaves also currently serves as the Company's Vice President, Technology and Operations, position he has held since November 2014. No new compensation arrangements were entered into between the Company and Mr. Hargreaves in connection with his appointment.